Johnson & Johnson submits application for subcutaneous Rybrevant dosing
6th May 2025 Uncategorised 0
Company seeks approval for new schedules to improve patient convenience

More: Johnson & Johnson submits application for subcutaneous Rybrevant dosing
Source: News
